Oak Ridge Investments LLC Incyte Corp Transaction History

Oak Ridge Investments LLC

$1.15 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$76.02 - $100.5 $1.63 Million - $2.15 Million	-21,397 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$80.74 - $97.7 $689,519 - $834,358	-8,540 Reduced 28.53%	21,397 $1.86 Million
Q3 2020 Nov 12, 2020	SELL	$85.07 - $109.69 $36,409 - $46,947	-428 Reduced 1.41%	29,937 $2.69 Million
Q2 2020 Aug 05, 2020	SELL	$74.18 - $108.93 $16,393 - $24,073	-221 Reduced 0.72%	30,365 $3.16 Million
Q1 2020 May 13, 2020	SELL	$63.18 - $85.97 $131,477 - $178,903	-2,081 Reduced 6.37%	30,586 $2.24 Million
Q4 2019 Feb 05, 2020	SELL	$73.04 - $95.72 $162,587 - $213,072	-2,226 Reduced 6.38%	32,667 $2.85 Million
Q3 2019 Nov 07, 2019	SELL	$72.82 - $86.52 $52,648 - $62,553	-723 Reduced 2.03%	34,893 $2.59 Million
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $254,305 - $306,813	-3,459 Reduced 8.85%	35,616 $3.03 Million
Q1 2019 May 09, 2019	BUY	$63.56 - $88.17 $297,460 - $412,635	4,680 Added 13.61%	39,075 $3.36 Million
Q4 2018 Feb 11, 2019	SELL	$58.5 - $69.94 $423,891 - $506,785	-7,246 Reduced 17.4%	34,395 $2.19 Million
Q3 2018 Nov 07, 2018	SELL	$61.75 - $74.23 $121,153 - $145,639	-1,962 Reduced 4.5%	41,641 $2.88 Million
Q2 2018 Aug 13, 2018	SELL	$60.85 - $83.98 $110,138 - $152,003	-1,810 Reduced 3.99%	43,603 $2.92 Million
Q1 2018 May 14, 2018	SELL	$83.06 - $100.98 $235,641 - $286,480	-2,837 Reduced 5.88%	45,413 $3.78 Million
Q4 2017 Feb 13, 2018	SELL	$93.56 - $116.6 $3.04 Million - $3.79 Million	-32,495 Reduced 40.24%	48,250 $4.57 Million
Q3 2017 Nov 07, 2017	SELL	$109.15 - $138.27 $1.34 Million - $1.69 Million	-12,233 Reduced 13.16%	80,745 $9.43 Million
Q2 2017 Aug 10, 2017	BUY	N/A	92,978	92,978 $11.7 Million

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Ridge Investments LLC with notifications on news.

Account